News
This was the stock's second consecutive day of losses.
Industry revenue for Hypodermic Single Lumen Needles is estimated to rise to $5.9 billion by 2035 from $2.6 billion of 2024.
Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage ...
Plants in Cobb County and Covington have been the subject of lawsuits by cancer patients claiming the release of ethylene ...
While investors have been initially skeptical, CEO Udit Batra explains why he believes this calculated risk will ultimately ...
The global Cancer Diagnostics Market is valued at USD 109.61 Billion in 2024 and is projected to reach a value of USD 215 ...
Overview of Cell Dissociation MarketThe global Cell Dissociation Market is valued at USD 620 Million in 2024 and is projected ...
According to Research by SNS Insider, U.S. Cancer Biomarkers Market to Surpass USD 22.70 Billion by 2032 Due to Rising Investment in Personalized Cancer Diagnostics.Austin, July 21, 2025 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results